Ingevity Corporation (NYSE:NGVT) Stock Has Average Price Target of $80.00

Shares of Ingevity Corporation (NYSE:NGVT) have been given an average recommendation of “Hold” by the five ratings firms that are presently covering the firm, MarketBeat reports. Three research analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is $80.00.

Several equities research analysts have commented on NGVT shares. Weiss Ratings upgraded shares of Ingevity from a “sell (d-)” rating to a “hold (c-)” rating in a research report on Friday, July 31st. Wall Street Zen downgraded Ingevity from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 1st.

Insider Buying and Selling at Ingevity

In related news, CEO David H. Li sold 5,000 shares of the business’s stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $75.83, for a total value of $379,150.00. Following the sale, the chief executive officer directly owned 120,636 shares in the company, valued at $9,147,827.88. The trade was a 3.98% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Ryan C. Fisher sold 2,709 shares of the stock in a transaction dated Monday, August 3rd. The shares were sold at an average price of $73.72, for a total transaction of $199,707.48. Following the completion of the sale, the senior vice president directly owned 15,722 shares in the company, valued at approximately $1,159,025.84. The trade was a 14.70% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 17,801 shares of company stock worth $1,347,481 in the last three months. 0.88% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Ingevity

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Assetmark Inc. lifted its stake in shares of Ingevity by 9.6% during the 1st quarter. Assetmark Inc. now owns 1,584 shares of the company’s stock worth $113,000 after purchasing an additional 139 shares during the period. Frazier Financial Advisors LLC purchased a new stake in shares of Ingevity in the second quarter valued at $37,000. Evolve Private Wealth LLC increased its stake in Ingevity by 10.2% in the first quarter. Evolve Private Wealth LLC now owns 5,946 shares of the company’s stock valued at $424,000 after purchasing an additional 549 shares during the last quarter. Lazard Asset Management LLC increased its stake in Ingevity by 6.3% in the first quarter. Lazard Asset Management LLC now owns 9,262 shares of the company’s stock valued at $660,000 after purchasing an additional 549 shares during the last quarter. Finally, Global Retirement Partners LLC purchased a new position in Ingevity during the second quarter worth about $45,000. Institutional investors and hedge funds own 91.59% of the company’s stock.

Ingevity Price Performance

Shares of NGVT opened at $71.53 on Friday. The company has a current ratio of 1.61, a quick ratio of 1.15 and a debt-to-equity ratio of 22.52. The stock’s 50 day moving average is $71.61 and its two-hundred day moving average is $71.89. Ingevity has a twelve month low of $45.85 and a twelve month high of $79.29. The firm has a market capitalization of $2.46 billion, a PE ratio of 48.66 and a beta of 1.14.

Ingevity (NYSE:NGVT) last issued its earnings results on Wednesday, July 29th. The company reported $1.74 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.33 by $0.41. Ingevity had a return on equity of 284.70% and a net margin of 4.65%.The business had revenue of $314.10 million during the quarter, compared to the consensus estimate of $312.20 million. Ingevity has set its FY 2026 guidance at 5.000-5.450 EPS. Research analysts anticipate that Ingevity will post 5.4 earnings per share for the current year.

Ingevity Company Profile

Ingevity Corporation (NYSE: NGVT) is a specialty chemicals and materials company headquartered in North Charleston, South Carolina. The company develops products designed to improve environmental performance, enhance infrastructure and support industrial manufacturing.

Ingevity’s products include activated carbon technologies used in automotive evaporative-emissions control systems, as well as applications involving air and water purification. The company also produces specialty chemicals and materials used in pavement preservation, asphalt modification and other industrial applications.